[Revision of the 3rd Consensus Conference in Intensive Care and Emergency Medicine in 1988: management of acute asthmatic crisis in adults and chidren (excluding infants)].
Experts designated by the "référentiels" committee of the SRLF analyzed the numerous articles published after the French consensus conference on the severe acute asthma of 1988. From their work, a revision of this consensus conference has been performed. The pediatric specificity has been added in this revision. There is no severity score able to predict the severity of acute asthma on admission. In every case, the nebulization of beta-2 agonists represents the priority treatment. The nebulization of anticholinergic associated with the beta-2 agonists induces a moderate additional effect. In the absence of response to nebulizations, the usefulness of the beta-2 agonists associated intravenous. Administration is not demonstrated. Corticosteroids should be administered using a 1 to 2 mg per kg dosage, but their efficacy is delayed. In adult patients, aminophylline should not be prescribe, but it is still used by some pediatricians. Other associated treatments (adrenaline, magnesium sulfate, helium-oxygen mixture) did not demonstrate their efficacy as adjunctive therapies. The therapeutic response should be evaluated using the peak flow determination.
L'her
E
E
Réanimation et urgences médicales, CHU de la Cavale Blanche, Brest, France. erwan@lher.net
D000208:Acute Disease; D000280:Administration, Inhalation; D000293:Adolescent; D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000328:Adult; D002648:Child; D002675:Child, Preschool; D004635:Emergency Medicine / Q000592:standards*; D006801:Humans; D007223:Infant; D007362:Intensive Care Units; D009330:Nebulizers and Vaporizers; D010372:Pediatrics; D017410:Practice Guidelines as Topic; D012720:Severity of Illness Index; D013224:Status Asthmaticus / Q000188:drug therapy* / Q000473:pathology
D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists